249 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd.
25 Sep 24
Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
8:05am
6-K
GLMD
Galmed Pharmaceuticals Ltd.
20 Sep 24
Current report (foreign)
4:46pm
6-K
GLMD
Galmed Pharmaceuticals Ltd.
19 Sep 24
Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
7:13am
6-K
GLMD
Galmed Pharmaceuticals Ltd.
16 Sep 24
Current report (foreign)
4:15pm
EFFECT
GLMD
Galmed Pharmaceuticals Ltd.
10 Sep 24
Notice of effectiveness
12:15am
424B3
m3z567
9 Sep 24
Prospectus supplement
4:30pm
F-1
dqsnt202exe897dapy
30 Aug 24
Registration statement (foreign)
4:25pm
6-K
6brlvup2e
30 Aug 24
Current report (foreign)
4:15pm
6-K
mdey4mvmp8 11t5mkl
28 Aug 24
Current report (foreign)
4:30pm
6-K
xsx2bu
27 Aug 24
Current report (foreign)
4:15pm
6-K
9zw158nchxqmfl
18 Jul 24
Current report (foreign)
4:30pm
6-K
g34hv q672ot8
11 Jul 24
Current report (foreign)
8:50am
6-K
zy9r3drakh514
5 Jun 24
Current report (foreign)
4:16pm
6-K
0cg12n5zqn
30 May 24
Current report (foreign)
4:30pm
6-K
993vv 4k6
19 Mar 24
Current report (foreign)
4:30pm
6-K
d5hjr
15 Mar 24
Current report (foreign)
9:13am
EFFECT
51ytpmhqsixsi9uyrh
30 Nov 23
Notice of effectiveness
12:15am
POS AM
yootlhw
22 Nov 23
Prospectus update (post-effective amendment)
4:48pm
6-K
i9ek7bt26jl0
22 Nov 23
Current report (foreign)
4:05pm